Menu
Contact Us
Subscribe
Menu

Sample Post Title!

By Author Name
3 min. read

Morbi libero lectus, laoreet elementum viverra vitae, sodales sit amet nisi. Vivamus dolor ipsum, ultrices in accumsan nec, viverra in nulla.

Donec ligula sem, dignissim quis purus a, ultricies lacinia lectus. Aenean scelerisque, justo ac varius viverra, nisl arcu accumsan elit, quis laoreet metus ipsum vitae sem. Phasellus luctus imperdiet.

Donec tortor ipsum

Pharetra ac malesuada in, sagittis ac nibh. Praesent mattis ullamcorper metus, imperdiet convallis eros bibendum nec. Praesent justo quam, sodales eu dui vel, iaculis feugiat nunc.

Pellentesque faucibus orci at lorem viverra, id venenatis justo pretium. Nullam congue, arcu a molestie bibendum, sem orci lacinia dolor, ut congue dolor justo a odio.

Duis odio neque, congue ut iaculis nec, pretium vitae libero. Cras eros ipsum, eleifend rhoncus quam at, euismod sollicitudin erat.

Fusce imperdiet, neque ut sodales dignissim, nulla dui. Nam vel tortor orci.

More technical briefs

The Role of Activism in Shaping Law and Policies that Support Access to Medicines

Ellen 't Hoen -
This article is also available as a PDF here. Almost 26 years ago, here in Amsterdam, on November 25-26, 1999, Health Action International, Médecins Sans...

Transfer of technology and know-how for the production of pandemic-related health products in the WHO Pandemic Agreement: The proverbial half glass 

Ellen 't Hoen -
A version of this brief was published on 13 June '25 by the Graduate Institute as part of their 'Governing Pandemic Snapshot' series: https://www.governingpandemics.org/gp-snapshot During...

Pharmaceutical patents and data exclusivity in an age of AI-driven drug discovery and development

Christopher Garrison -
This is an excerpt from a longer report on AI, medicines development and the patent system. Download the full report here (or by clicking...

Continuing to ignore the problem of the know-how gap won’t make it go away.

Christopher Garrison -
The Covid-19 pandemic was a wake-up call for a variety of issues in access to medicines, one of which was finding a solution to...
Load more

Related Articles

Medicines Law & Policy statement at WHO PABS negotiations (IGWG 5)

Ellen 't Hoen -
Co-chairs, Thank you for the opportunity to say a few words.  My comments address issues related to technology transfer (TT), a topic we have been...

Legal tools that lower medicines prices have expanded access to medicines for over two decades, research reveals

Montgomery Dunn -
LONDON, UK: Millions of people are priced out of access to life-saving medicines. Use of legal tools to reduce prices has been under-reported and...

Wrapping up 2025: A tumultuous year for global public health law & policy

Medicines Law & Policy -
The end of 2025, a tumultuous year for global public health, is here, and it’s time for the usually highly biased Medicines Law &...

The Role of Activism in Shaping Law and Policies that Support Access to Medicines

Ellen 't Hoen -
This article is also available as a PDF here. Almost 26 years ago, here in Amsterdam, on November 25-26, 1999, Health Action International, Médecins Sans...
Load more

Newsletter

Never miss a post! Sign up for ML&P's newsletter.

Recent Articles

Medicines Law & Policy statement at WHO PABS negotiations (IGWG 5)

Ellen 't Hoen -
Co-chairs, Thank you for the opportunity to say a few words.  My comments address issues related to technology transfer (TT), a topic we have been...

Legal tools that lower medicines prices have expanded access to medicines for over two decades, research reveals

Montgomery Dunn -
LONDON, UK: Millions of people are priced out of access to life-saving medicines. Use of legal tools to reduce prices has been under-reported and...

Wrapping up 2025: A tumultuous year for global public health law & policy

Medicines Law & Policy -
The end of 2025, a tumultuous year for global public health, is here, and it’s time for the usually highly biased Medicines Law &...

The Role of Activism in Shaping Law and Policies that Support Access to Medicines

Ellen 't Hoen -
This article is also available as a PDF here. Almost 26 years ago, here in Amsterdam, on November 25-26, 1999, Health Action International, Médecins Sans...

Generic versions of a lifesaving cystic fibrosis treatment will save patients $360,000 a year – expanding access and prolonging lives

Kaitlin Mara -
Generic versions of a cystic fibrosis treatment will now be available at $6,375 per child, per year under a new scheme – offering hope...
Load more

Medicines Law & Policy

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.

Never miss a post! Sign up for ML&P's newsletter.

This work is licensed under Creative Commons. You are free to share, with attribution and without changes, for non-commercial purposes.